Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase

Overview of attention for article published in Journal of Medicinal Chemistry, March 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Dimensions has found 9 publications that cite this research output.

Article in RSC Medicinal Chemistry (January 2021)

Article in Platelets (December 2020)

Article in European Journal of Medicinal Chemistry (December 2020)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.